These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17061219)

  • 1. Is there any relationship between photodynamic therapy for exudative age-related macular degeneration and choroidal neovascolarization recurrence? A rationale for combined treatments.
    Piermarocchi S; Sartore M; Lo Giudice G; Monterosso G; Pilotto E; Segato T
    Eur J Ophthalmol; 2006; 16(5):686-94. PubMed ID: 17061219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.
    Parodi MB; Da Pozzo S; Ravalico G
    Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration.
    Obata R; Yanagi Y; Kami J; Takahashi H; Inoue Y; Tamaki Y
    Jpn J Ophthalmol; 2006; 50(4):354-360. PubMed ID: 16897221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic findings in patients with exudative age-related macular degeneration.
    Bermig J; Tylla H; Jochmann C; Nestler A; Wolf S
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):169-75. PubMed ID: 11935273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
    Ladd BS; Solomon SD; Bressler NM; Bressler SB
    Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
    Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
    Verteporfin In Photodynamic Therapy Study Group
    Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term reaction of choroidal neovascularization and choriocapillaris to photodynamic therapy in age-related macular degeneration.
    Eter N; Vogel A; Inhetvin-Hutter C; Spitznas M
    Eur J Ophthalmol; 2003 Oct; 13(8):687-92. PubMed ID: 14620172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Photodynamic therapy with verteporfin in occult choroidal neovascularization in age-related macular degeneration].
    Kürzinger GR; Stender B; Lang GK; Lang GE
    Klin Monbl Augenheilkd; 2010 Jun; 227(6):501-6. PubMed ID: 20349399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence of early vascular events after photodynamic therapy.
    Michels S; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM; Michels S
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration.
    Haddad WM; Coscas G; Soubrane G
    Br J Ophthalmol; 2002 Jun; 86(6):663-9. PubMed ID: 12034690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
    Hamon F; Goeminne P
    Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy for age-related macular degeneration.
    Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L
    Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.